Show Notes
Health Affairs This Week
is on a break this week. Today, we are publishing an episode from A Health Podyssey
, where Health Affairs
Editor-in-Chief Alan Weil brings you in-depth conversations with leading researchers and influencers shaping the big ideas in health policy and the health care industry. Health Affairs This Week
will return next week.
Subscribe to
A Health Podyssey:
RSS |
Apple Podcasts |
Spotify |
Stitcher |
Google Podcasts The United States is facing a drug affordability crisis.
Even as we celebrate scientific discovery, the health benefits of drugs are limited due to barriers of affordability, often even for people with health insurance. The RAND Corporation reports that on average drug prices in the United States are more than two and a half times those in 32 other nations studied. The disparities are even wider when we focus just on brand name drugs.
Drug pricing is the subject of seemingly perennial debates. One side focuses on access barriers due to high prices while the other side argues that lower prices threaten future innovation.
Stacie Dusetzina from Vanderbilt University Medical Center joins A Health Podyssey to talk about the complex world of drug pricing.
From our advertiser: Our UnitedHealthcare Community & State newsletter is your go-to source for the latest Medicaid news and UnitedHealthcare programs serving Medicaid beneficiaries. Subscribe now by visiting our website at
UHCCS.com/Newsletter. Stay in the know by gaining access to our latest blogs, educational videos and upcoming events.